3 embarrassingly-cheap dividend stocks

These dividend stocks are cheap for a reason, but as this Fool explains, the potential rewards could be worth the risks of buying.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

When I’m looking for dividend stocks to buy, I tend to focus on companies that look cheap compared to their potential. 

This strategy might not be suitable for all investors. More often than not, when a stock looks cheap, there is a reason why. 

Dividend stocks on offer

One of my favourite dividend Investments is British American Tobacco (LSE: BATS). This embarrassingly-cheap dividend stock currently offers a dividend yield of 7.9%. It also trades at a discounted price-to-earnings (P/E) multiple of 8.3. 

It’s clear why the market hasn’t rewarded the company with a higher multiple, and that’s because of the group’s exposure to tobacco. 

Cigarette consumption worldwide is declining on a per capita basis, which means sooner or later British American’ customer numbers could dwindle significantly. 

This risk aside, the company’s been a dividend champion for years. Profits have increased steadily over the past five years, rising at a compound annual rate of 8.3%.

Analysts expect this trend to continue as the company increases sales of reduced-risk products and increases prices across its product portfolio. And as long as the direction of increasing profits continues, I’d like to own the stock in my portfolio.

Complex balance sheet

Another company that features my list of embarrassingly-cheap dividend stocks is Phoenix (LSE: PHNX). There’s nothing wrong with this group per se, but it’s one that isn’t easy to understand.

The firm specialises in the acquisition and management of closed life insurance and pension funds. It rolls up acquired funds and uses its scale to achieve operating synergies. These synergies increase cash generation, which it can then return to shareholders. 

The enterprise can be challenging to understand because it has a complex balance sheet full of different assets and derivatives. What’s more, as the company is trying to manage assets today that will be paid out in the future, it’s highly susceptible to even small changes in interest rates. These could throw off the group’s calculations and cause financial problems. 

However, I’m willing to invest in the business because I understand how it operates. That’s why I’d snap up the shares and their 7% dividend yield today while they’re trading at a discounted P/E of 8.4.

Risky environment 

Finally, I’d buy discounted Russian steel producer Evraz (LSE: EVR) from my portfolio of dividend stocks. I don’t really have to explain why investors have been avoiding this business. Russia has always been a volatile place to invest, and it’s only really suitable for the most risk-tolerant investors. If the state suddenly decides it doesn’t like Evraz, the company’s fortunes could change virtually overnight. 

That said, shareholders are rewarded for taking on the risk. The stock currently supports a dividend yield of 12.5%. The company is presently benefiting significantly from increased demand for steel and other construction products. Based on current earnings projections, the shares are dealing at a forward P/E of just 5.8. 

Looking at these figures, I’d buy Evraz for my portfolio of dividend stocks today despite the risks of investing in the company. I think its cheap valuation and high level of income offset the risks involved. 

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Rupert Hargreaves owns shares of British American Tobacco. The Motley Fool UK has recommended British American Tobacco. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »